Annual CFO
-$46.13 M
-$16.84 M-57.49%
December 31, 2023
Summary
- As of February 7, 2025, OBIO annual cash flow from operations is -$46.13 million, with the most recent change of -$16.84 million (-57.49%) on December 31, 2023.
- During the last 3 years, OBIO annual CFO has fallen by -$19.94 million (-76.17%).
- OBIO annual CFO is now -137.41% below its all-time high of -$19.43 million, reached on December 31, 2021.
Performance
OBIO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$13.70 M
-$3.49 M-34.23%
September 30, 2024
Summary
- As of February 7, 2025, OBIO quarterly cash flow from operations is -$13.70 million, with the most recent change of -$3.49 million (-34.23%) on September 30, 2024.
- Over the past year, OBIO quarterly CFO has dropped by -$3.42 million (-33.24%).
- OBIO quarterly CFO is now -157.33% below its all-time high of -$5.32 million, reached on March 31, 2022.
Performance
OBIO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$47.99 M
-$3.42 M-7.67%
September 30, 2024
Summary
- As of February 7, 2025, OBIO TTM cash flow from operations is -$47.99 million, with the most recent change of -$3.42 million (-7.67%) on September 30, 2024.
- Over the past year, OBIO TTM CFO has dropped by -$4.10 million (-9.33%).
- OBIO TTM CFO is now -801.47% below its all-time high of -$5.32 million, reached on March 31, 2022.
Performance
OBIO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
OBIO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -57.5% | -33.2% | -9.3% |
| 3 y3 years | -76.2% | -56.7% | -63.9% |
| 5 y5 years | -76.2% | -56.7% | -63.9% |
OBIO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -137.4% | at low | -157.3% | +4.7% | -801.5% | at low |
| 5 y | 5-year | -137.4% | at low | -157.3% | +4.7% | -801.5% | at low |
| alltime | all time | -137.4% | at low | -157.3% | +4.7% | -801.5% | at low |
Orchestra BioMed Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.70 M(+34.2%) | -$47.99 M(+7.7%) |
| Jun 2024 | - | -$10.21 M(-22.2%) | -$44.58 M(-0.6%) |
| Mar 2024 | - | -$13.11 M(+19.5%) | -$44.86 M(-2.7%) |
| Dec 2023 | -$46.13 M | -$10.97 M(+6.7%) | -$46.13 M(+5.1%) |
| Sep 2023 | - | -$10.28 M(-2.0%) | -$43.90 M(+7.4%) |
| Jun 2023 | - | -$10.49 M(-27.1%) | -$40.87 M(+6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$14.38 M(+64.5%) | -$38.35 M(+30.9%) |
| Dec 2022 | -$29.29 M(+50.7%) | -$8.74 M(+20.5%) | -$29.29 M(+42.6%) |
| Sep 2022 | - | -$7.26 M(-8.9%) | -$20.55 M(+54.6%) |
| Jun 2022 | - | -$7.96 M(+49.6%) | -$13.29 M(+149.6%) |
| Mar 2022 | - | -$5.32 M | -$5.32 M |
| Dec 2021 | -$19.43 M(-25.8%) | - | - |
| Dec 2020 | -$26.18 M | - | - |
FAQ
- What is Orchestra BioMed Holdings annual cash flow from operations?
- What is the all time high annual CFO for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings annual CFO year-on-year change?
- What is Orchestra BioMed Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings quarterly CFO year-on-year change?
- What is Orchestra BioMed Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings TTM CFO year-on-year change?
What is Orchestra BioMed Holdings annual cash flow from operations?
The current annual CFO of OBIO is -$46.13 M
What is the all time high annual CFO for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high annual cash flow from operations is -$19.43 M
What is Orchestra BioMed Holdings annual CFO year-on-year change?
Over the past year, OBIO annual cash flow from operations has changed by -$16.84 M (-57.49%)
What is Orchestra BioMed Holdings quarterly cash flow from operations?
The current quarterly CFO of OBIO is -$13.70 M
What is the all time high quarterly CFO for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high quarterly cash flow from operations is -$5.32 M
What is Orchestra BioMed Holdings quarterly CFO year-on-year change?
Over the past year, OBIO quarterly cash flow from operations has changed by -$3.42 M (-33.24%)
What is Orchestra BioMed Holdings TTM cash flow from operations?
The current TTM CFO of OBIO is -$47.99 M
What is the all time high TTM CFO for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high TTM cash flow from operations is -$5.32 M
What is Orchestra BioMed Holdings TTM CFO year-on-year change?
Over the past year, OBIO TTM cash flow from operations has changed by -$4.10 M (-9.33%)